NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-117-2021-1-EP-01 D3 Dopamine Receptor-Selective Negative Allosteric Modulators. EP National Stage 22761746.1 Pending
NIDCR E-129-2021-0-IL-01 AQP1 Gene Therapy To Prevent Radiation-Induced Salivary Hypofunction IL National Stage 310485 Pending
NHLBI E-090-2020-0-US-02 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND
METHODS OF USE 		US DIV 18/425,487 Pending
NIAID E-050-2018-0-US-08 NIPAH VIRUS IMMUNOGENS AND THEIR USE US DIV 18/424,606 Pending
NCI E-175-2016-0-US-02 ANTI-KRAS-G12D T CELL RECEPTORS US CON 18/423,020 Pending
NCI E-048-2021-0-AU-01 HIV-1 VACCINATION AND SAMT-247 MICROBICIDE TO PREVENT HIV-1 INFECTION AU National Stage 2022323509 Pending
NCI E-199-2022-0-PC-01 HUMAN PAPILLOMAVIRUS, VARICELLA-ZOSTER VIRUS, AND RABIES VIRUS ANTIGENS AND USES THEREOF IN CANCER IMMUNOTHERAPY PCT PCT PCT/US2024/012976 Pending
NHLBI E-039-2022-0-US-02 TEMPERATURE CYCLING METHOD FOR HYPERPOLARIZATION OF TARGET MOLECULES AND CONTRAST AGENTS USING PARAHYDROGEN US National Stage 18/291,681 Pending
NIAID E-052-2017-4-AU-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection AU DIV 2024200395 Pending
NHLBI E-091-2021-0-EP-01 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE EP National Stage 22743679.7 Pending
NICHD E-209-2021-0-US-04 Kits And Methods To Distinguish False Labor And True Labor US CON 18/414,339 Pending
NIAID E-135-2010-0-US-02 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US CON 18/411,997 Pending
NINDS E-047-2023-1-PC-01 Genetic control of MRI signal PCT PCT PCT/US2024/011377 Pending
NCI E-053-2024-0-PC-01 PKM1/HLT2 NANOPARTICLE/HYDROGEL COMPOSITE FOR MIRNA DELIVERY PCT PCT PCT/US2024/011463 Pending
NCATS E-114-2018-0-JP-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS JP DIV 2024-003447 Pending
NCI E-094-2017-0-CN-01 Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy CN DIV 202410048366.X Pending
NCI E-181-2017-0-CR-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CR DIV 2024-0019 Pending
NCI E-058-2023-0-PC-01 BICYCLIC CARBAMOYL PYRIDONE-BASED INTEGRASE STRAND TRANSFER INHIBITORS PCT PCT PCT/US2024/011244 Pending
NHLBI E-036-2022-0-US-03 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS US CIP 18/410,773 Pending
NIAID E-064-2016-1-US-10 PREFUSION RSV F PROTEINS AND THEIR USE US CON 18/409,645 Pending
NIBIB E-040-2023-1-PC-01 INTUBATION SYSTEM AND CHAMBER TANK PCT PCT PCT/US2024/011071 Pending
NEI E-293-2016-0-JP-09 TISSUE CLAMP AND IMPLANTATION METHOD JP DIV 2024-617 Pending
NHGRI E-034-2019-0-JP-01 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA JP DIV 2024-000692 Pending
NIAID E-052-2017-0-TW-01 Trispecific Binding Protein TW DIV 113100534 Pending
NEI E-164-2021-0-MX-01 SUPPRESSION OF UVEITIS BY SINGLE DOMAIN ANTIBODY MX National Stage MX/a/2024/000309 Pending
NCATS E-192-2022-0-PC-03 SDR Assay: A General High Throughout Binding Assay Strategy Based On A Ligand-biased Structural Dynamics Response. PCT PCT PCT/US2024/010333 Pending
NCI E-101-2021-0-CN-05 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 CN National Stage 202280047288.0 Pending
NHLBI E-057-2024-0-EP-01 Use of LMO4 to bolster stemness and antitumor efficacy of T-cells EP ORD 24150070.1 Pending
NCI E-205-2010-2-JP-01 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2023-220785 Pending
NCI E-175-2016-0-JP-01 ANTI-KRAS-G12D T CELL RECEPTORS JP DIV 2023-221526 Pending
NIDDK E-032-2023-0-PC-01 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION PCT PCT COMB PCT/US2023/085968 Pending
NCI E-067-2017-0-US-02 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES US DIV 18/397,448 Pending
NCI E-182-2017-0-JP-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION JP DIV 2023-220106 Pending
NHLBI E-091-2021-0-CN-01 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE CN National Stage 202280044857.6 Pending
NIAID E-004-2023-1-PC-01 EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES PCT PCT PCT/US2023/085745 Pending
NIAID E-004-2023-0-PC-01 EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES PCT PCT PCT/US2023/085739 Pending
NICHD E-037-2023-0-PC-01 Single Source-Detector Separation Approach to Calculate Tissue Oxygen Saturation PCT PCT PCT/US2023/085725 Pending
NIAID E-030-2023-0-PC-01 STABILIZED PFS48/45 PROTEINS AND USES THEREOF PCT PCT PCT/US2023/085849 Pending
NCI E-106-2021-0-EP-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME EP National Stage 22741091.7 Pending
NIDDK E-112-2021-0-EP-01 Vitamin C Renal Leak As A Clinical Diagnostic Tool In The Detection, Monitoring And Management Of Acute And Chronic Diseases EP National Stage 22732782.2 Pending
NCI E-106-2021-0-AU-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME AU National Stage 2022288631 Pending
NHLBI E-091-2021-0-US-02 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE US National Stage 18/572,462 Pending
NEI E-155-2020-0-EP-04 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS EP National Stage 22736412.2 Pending
NCI E-229-2014-0-AU-01 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation AU DIV 2023285735 Pending
NCI E-171-2020-0-HK-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection HK EP 62023084208.5 Pending
NIAID E-216-2021-0-US-02 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery US National Stage 18/570,579 Pending
NIAID E-024-2023-0-PC-01 MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION PCT PCT PCT/US2023/084255 Pending
NEI E-153-2020-0-EP-06 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells EP National Stage 22732802.8 Pending
NIAID E-202-2018-0-US-04 USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION US CON 18/538,065 Pending
NIAID E-215-2016-1-US-01 PREFUSION PIV F IMMUNOGENS AND THEIR USE US DIV 18/537,448 Pending